Best Growth Stocks to Buy for October 13th

07:31am, Friday, 13'th Oct 2023
PANW, SEM and LW made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13, 2023.

Best Income Stocks to Buy October 13th

06:01am, Friday, 13'th Oct 2023
FANG, SEM and KUBTY made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 13, 2023.

Best Growth Stocks to Buy for October 10th

07:31am, Tuesday, 10'th Oct 2023
SEM, JELD and URBN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 10, 2023.
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical (SEM), EnerSys (ENS), Marathon Oil (MRO) and Adtalem Global (ATGE) boast a low P/CF
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), Pampa Energia (PAM), Compania Cervecerias Unidas (CCU), Paysafe Limited (P
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

5 Low Price-to-Book Stocks to Buy in September

09:46am, Thursday, 14'th Sep 2023
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), Office Properties Income Trust (OPI), KB Financial Group (KB), PagSeguro D
Interest rates impact the healthcare industry and medical device companies in various ways. Here we discuss three companies HCA, ALC and SEM that are likely to gain potential pause in rate hikes.
Select Medical (SEM) is well-poised for growth on the back of a credible healthcare facility portfolio built through buyouts and JVs coupled with strong cash-generating abilities.
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), General Motors Company (GM), KB Financial Group (KB), StoneCo Ltd.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Select Medical's (SEM) Q2 results reflect solid segmental revenues, attributable to higher patient days and outpatient visits. Management projects adjusted EPS of $1.86-$2.03 for 2023.
Select Medical (SEM) is well-poised for growth on the back of improved patient volumes, an expanding healthcare portfolio and solid cash-generating abilities.
Select Medical (SEM) expects revenues to be within the range of $6.5-$6.7 billion in 2023, indicating a rise of 4.8% from the 2022 figure of $6.3 billion.
Select Medical (SEM) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.37 per share a year ago.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE